Telo Genomics Corp.
TDSGF
$0.0882
$0.020630.47%
| Weiss Ratings | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.65 | |||
| Price History | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.01% | |||
| 30-Day Total Return | -13.53% | |||
| 60-Day Total Return | 10.53% | |||
| 90-Day Total Return | -16.08% | |||
| Year to Date Total Return | 8.75% | |||
| 1-Year Total Return | -0.90% | |||
| 2-Year Total Return | -48.51% | |||
| 3-Year Total Return | -67.82% | |||
| 5-Year Total Return | -13.95% | |||
| 52-Week High % Change | -62.30% | |||
| 52-Week Low % Change | 24.95% | |||
| Price | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.18 | |||
| 52-Week Low Price | $0.05 | |||
| 52-Week Low Price (Date) | Feb 26, 2025 | |||
| 52-Week High Price (Date) | Jun 21, 2024 | |||
| Valuation | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 9.04M | |||
| Enterprise Value | 7.48M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.03 | |||
| Earnings Per Share Growth | -20.74% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 5.54 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.09 | |||
| Enterprise Value/EBITDA (TTM) | -3.71 | |||
| Enterprise Value/EBIT | -3.67 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 76.77M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 673 8487 | |||
| Address | MaRS Centre Toronto, ON M5G 1L7 | |||
| Website | www.telodx.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -78.48% | |||
| Return on Equity | -- | |||
| Income Statement | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -1.73M | |||
| EBIT (TTM) | -1.75M | |||
| Net Income (TTM) | -1.73M | |||
| Net Income Avl. to Common (TTM) | -1.73M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 28.52% | |||
| EPS Diluted (TTM) | -0.03 | |||
| EPS Diluted Growth (Q YOY) | 17.44% | |||
| Balance Sheet | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.56M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 1.61M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.22M | |||
| Current Ratio (Q) | 3.834 | |||
| Book Value Per Share (Q) | $0.01 | |||
| Total Assets (Q) | 1.64M | |||
| Total Current Liabilities (Q) | 419.60K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 419.60K | |||
| Total Common Equity (Q) | 1.22M | |||
| Cash Flow | TDSGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.70K | |||
| Cash from Financing (TTM) | 2.09M | |||
| Net Change in Cash (TTM) | 657.40K | |||
| Levered Free Cash Flow (TTM) | -783.00K | |||
| Cash from Operations (TTM) | -1.43M | |||
